The symptoms of ataxia-telangiectasia (A-T) include a progressive neurodegeneration caused by ATM protein deficiency. We previously found that nuclear accumulation of histone deacetylase-4, HDAC4, contributes to this degeneration; we now report that increased trimethylation of histone H3 on Lys27 (H3K27me3) mediated by polycomb repressive complex 2 (PRC2) is also important in the A-T phenotype. Enhancer of zeste homolog 2 (EZH2), a core catalytic component of PRC2, is a new ATM kinase target, and ATM-mediated phosphorylation of EZH2 on Ser734 reduces protein stability. Thus, PRC2 formation is elevated along with H3K27me3 in ATM deficiency. Chromatin immunoprecipitation and sequencing showed an increase in H3K27me3 'marks' and a dramatic shift in their location. The change of H3K27me3 chromatin-binding pattern is directly related to cell cycle reentry and cell death of ATM-deficient neurons. Lentiviral knockdown of EZH2 rescued Purkinje cell degeneration and behavioral abnormalities in Atm −/− mice, demonstrating that EZH2 hyperactivity is another key factor in A-T neurodegeneration.
Ataxia-telangiectasia (A-T) is a multisystem disease characterized in the CNS by neurodegeneration [1] [2] [3] [4] . The earliest and most profound neuropathology involves the Purkinje and granule cells of the cerebellum. A-T is caused by mutation of the A-T mutated (ATM) gene, which is ubiquitously expressed throughout development and encodes a serine/threonine protein kinase of the phosphatidylinositol-3 kinase-related kinase (PIKK) family 5 . The best-known function of ATM is to ensure the integrity of the genome. After DNA damage, ATM activates cell cycle checkpoints, arresting the cycle until DNA repair is complete 6 . Its role in maintaining the health and survival of neurons is complex. Consistent with its function in DNA damage repair 7 , ATM protects postmitotic neurons from degeneration by suppressing the cell cycle [8] [9] [10] . But ATM is also required for neuronal vesicle trafficking 11 and maintaining HDAC4 (histone deacetylase 4) in the cytoplasm 12 . Both of these processes are crucial for neuronal viability, and yet neither is directly induced by DNA damage 12 . These later observations hint at a complex web of nerve cell phenotypes that depend on ATM function and suggest that the mechanisms behind the neurodegeneration in A-T are multifaceted and still incompletely defined.
Our finding of ectopic nuclear HDAC4 in ATM deficiency and the subsequent genome-wide alterations in the acetylation marks on histones H3 and H4 led us to explore other aspects of the histone code. Polycomb group (PcG) family proteins are transcriptional repressors that epigenetically modify chromatin and participate in the establishment and maintenance of many cell fates [13] [14] [15] [16] [17] . PcG proteins participate in both stem cell self-renewal and tumorigenesis, as well as in brain development 18, 19 . In mammals, there are two distinct polycomb protein complexes: polycomb repressive complex 1 (PRC1) and PRC2 (ref. 20) . The PRC2 complex consists of EZH2 (enhancer of zeste homolog 2), SUZ12 (suppressor of zeste 12) and EED (embryonic ectoderm development) 21 . EZH2 catalyzes the addition of methyl groups to histone H3 at Lys27 (H3K27) in target gene promoters, leading to epigenetic silencing. EZH2 plays a role in X-chromosome inactivation, germ line development, cell fate decisions and stem cell pluripotency 14, 15, 22, 23 . EZH2 is overexpressed in aggressive solid tumors, and its overexpression has been implicated in cancer progression and metastases 15, 24, 25 ; its knockdown leads to decreased proliferation of cancer cells and a delay in the G2-M cell cycle transition. During development and stem cell maturation, EZH2 interacts with cyclin-dependent kinase-1 (CDK1) or CDK2 to integrate developmental cues and cell cycle activity, thus controlling self-renewal or differentiation 15, 25 . EZH2 also regulates the balance between self-renewal and differentiation of cortical neurons 26, 27 .
Histone modification is a major form of epigenetic gene regulation that is critical in many neuronal processes 28, 29 . Spurred by our finding of dramatic HDAC4-mediated histone acetylation changes in Atm-deficient neurons, we asked whether EZH2-mediated H3K27 trimethylation is also affected by a defect of ATM function. We now report that in the cerebella of A-T patients and in A-T mouse models, the levels of H3K27 trimethylation are elevated as a result of the loss of ATM-dependent EZH2 phosphorylation. This phosphorylation normally destabilizes EZH2, thus reducing its association with the PRC2 complex and reducing subsequent H3K27 methylation. Chromatin immunoprecipitation (ChIP) and sequencing (ChIPseq) using H3K27me3 antibody revealed genome-wide differences in this histone mark between wild-type and Atm −/− mice. These differences help to drive the CNS symptoms of A-T; knockdown of EZH2 prevents cell cycle reentry and neuronal death in Atm-deficient neurons and improves behavior of Atm −/− mice. We propose a model of A-T in which EZH2-mediated hypermethylation of H3K27me3 is a crucial step leading to the degeneration of the Atm-deficient neurons. a r t I C l e S RESULTS Elevated H3K27me3 in A-T brains EZH2-mediated H3K27 trimethylation is a key activity of the polycomb epigenetic system. It affects many processes, including proliferation, tumorigenesis and brain development 15, 22, 30 . We became interested in EZH2 as a possible player in A-T because of its roles in cell cycle regulation. ATM-deficient Purkinje and granule cells both reenter the cell cycle before dying in human A-T and in its Atm −/− mouse model 10, 31 . We speculated that, if EZH2 is involved, the disease process in the A-T nervous system might derive in part from the overactivation of PRC2.
As H3K27 is the main target of EZH2, first, we examined H3K27me3 in human cerebellar cortex. Purkinje and granule cell nuclei contained low levels of H3K27me3 in healthy control cerebellar sections ( Fig. 1a , top, and Fig. 1b ). Yet, as predicted by our hypothesis, both neuronal types in sections from A-T patients showed enhanced nuclear H3K27me3 staining; H3K9me3 was unaffected (Fig. 1a , bottom, and Fig. 1b ). Western blots of tissue extracts validated the immunostaining, showing elevated H3K27me3 in A-T compared to control ( Fig. 1c) . We next repeated these observations in Atm −/− mice. Immunostaining for H3K27me3 ( Fig. 1d , top, and Fig. 1e ), but not H3K9me3 (Fig. 1d , bottom, and Fig. 1e ), was substantially increased in Atm −/− Purkinje cell nuclei. We also found increased H3K27me3 in mouse Atm −/− neocortex and hippocampus ( Fig. 1f and Supplementary Fig. 1a ). As expected, an increased interaction of H3K27me3 with EZH2 was also found in ATM deficiency (Supplementary Fig. 1b,c) . Thus, there is a close association between elevated H3K27me3 and Atm deficiency in both humans and mice.
EZH2 is an ATM target
The remarkable change in the levels of H3K27me3 in A-T brain suggested that EZH2 might be an ATM target. Analysis of the EZH2 protein sequence predicts that two serines, Ser652 and Ser734, are highly probable sites of ATM phosphorylation. We could find no comparably favorable sites in the EZH1 histone methyltransferase, nor in other members (for example, Suz12) of PRC2, to which EZH2 belongs. To determine whether these two EZH2 sites are used as ATM targets in vivo, we prepared cerebellar extracts from brain autopsy material either from individuals who died with no neurological disease or from A-T patients, as well as from wildtype and Atm −/− mice and performed immunoprecipitation with EZH2 or EZH1 antibodies. Western blots of the immunoprecipitates were then probed with an antibody against a phosphorylated serine or threonine in the context of a following glutamine residue ( P [S/T]Q), the canonical ATM target site 32, 33 . We found a strong P [S/T]Q signal on the EZH2 band in control samples but not in A-T or Atm −/− extracts ( Fig. 2a) . There was no P [S/T]Q signal in either genotype using EZH1 immunoprecipitates ( Fig. 2a) . We verified that Ser734 is the predominant ATM site on EZH2 by performing ATM in vitro kinase assays using glutathione S-transferase (GST)-EZH2 fusion proteins as substrates (Fig. 2b) . The phosphorylation signal was nearly lost when the EZH2-S734A mutant was used as substrate; the S652A S734A (2SA) double mutation blocked the phosphorylation signal entirely. This indicates that Ser734 is the main ATM phosphorylation site, but Ser652 may serve as an alternative kinase target. To confirm whether ATM-mediated EZH2 phosphorylation responds to DNA damage in vivo, we overexpressed GFP-EZH2 wild type or the nonphosphorylatable 2SA mutant in human A-T fibroblasts with Flag-ATM wild type (WT) or the kinase dead (KD) mutant. A strong P [S/T]Q signal was found with etoposide treatment when GFP-EZH2-WT was expressed with Flag-ATM-WT ( Fig. 2c) . Expression of either the EZH2-2SA mutant or the ATM-KD mutant substantially reduced the response. In mature neurons, the levels of EZH2 are normally very low 26 , a finding that we verified in wild-type mouse and human disease-free cerebella (Fig. 2d,e and Supplementary Fig. 2a ). In A-T cerebellum and Atm −/− cerebellum, by contrast, levels of EZH2 were substantially higher ( Fig. 2d,e ). Elevated levels of EZH2 were also found in other regions of the Atm −/− brain, such as neocortex and hippocampus ( Fig. 2e and Supplementary Fig. 2b ), suggesting that this effect may be a general one. The enhanced levels of EZH2 protein in ATMdeficient neurons were likely not a result of increased transcription; by reverse transcription (RT)-PCR, Ezh2 mRNA levels were nearly equal in the two genotypes ( Supplementary Fig. 2c,d) .
As a core protein of the polycomb repressive complex 2 (PRC2), the function and enzymatic activity of EZH2 relies on its physical interaction with the other PRC2 proteins. When we overexpressed EZH2 in N2a mouse neuroblastoma cells, we found that, compared to that of wild-type EZH2, the association with EED and Suz12 was stronger with the nonphosphorylatable 2SA mutant and weaker with a phosphomimetic mutant, 2SD, which carries both the S652D and S734D mutations ( Fig. 2f) . To assess whether the stability of EZH2 affects its ability to participate in PRC2 complex formation, we used the protein synthesis inhibitor cycloheximide to block new protein synthesis, then followed the degradation of the existing pools of protein. After overexpression in N2a cells, wild-type EZH2 had a protein half-life of 17.3 h ( Fig. 2g,h) . The half-life of the 2SD phosphomimetic mutant was comparable (data not shown). By contrast, the nonphosphorylatable 2SA mutant had a half-life of approximately 2 d ( Fig. 2g,h) . In all cases, stability was directly correlated with increased EZH2 binding to H3K27me3 (Fig. 2f) . Endogenous EZH2 protein in human A-T fibroblasts behaved similarly: more stable after cycloheximide treatment than EZH2 in cycloheximide-treated control fibroblasts ( Supplementary Fig. 3a,b ). Next we tested whether inhibiting protease activity with ALLN (N-acetyl-Leu-Leu-norleucinal) blocked the degradation of nonphosphorylatable EZH2. When given 24 h after transfection of GFP-EZH2, protease inhibition blocked the degradation of the 2SA EZH2 mutant ( Supplementary Fig. 3c,d) . These data suggest that PRC2 complex formation is enhanced in ATM deficiency and that this protects EZH2 from degradation.
H3K27me3 chromatin-binding correlates with transcription
The substantially increased levels of H3K27me3 in ATM-deficient neurons led us to ask whether the evidence of altered chromatin remodeling was related to the elevated levels of EZH2. We thus performed H3K27me3 ChIP from Atm −/− cerebellar cortex. We found npg a r t I C l e S a fourfold increase in the number of H3K27me3 binding sites in Atm −/− compared to the number in wild-type chromatin ( Fig. 3a and Supplementary Fig. 4a ).
In addition, this increase was accompanied by a substantial shift in the pattern of binding: just 5% of the sites identified in wild-type chromatin overlapped with the sites found in Atm −/− . Most of the Atm −/− binding sites (93%) were not represented in the wild type, and of the total wild-type sites identified, only 23% were found in Atm −/− as well. Despite these local shifts in discrete binding sites at the genomic level, the increased in H3K27me3 density was uniformly distributed over genome ( Supplementary  Fig. 4b ). Analyzed by gene function, a large proportion of H3K27me3 targets were in categories that include neuronal function and cell cycle regulation ( Supplementary Table 1 ), but the peaks in the different genotypes did not show a striking difference in gene ontology (Supplementary Table 1 ). Among genes identified in this analysis were Slit1, Synj2 and Nlgn1-genes with important function in synaptic development and maintenance. We confirmed the H3K27me3 marking of each of these genes by quantitative PCR (qPCR) (Fig. 3b,c) . We also found H3K27me3 enrichment in promoter areas of the cell cycle regulatory genes Cdkn2a and Cdkn2b in Atm −/− samples compared to wild type ( Supplementary Fig. 5a,b) . All ChIP-qPCR assays displayed increased enrichment of H3K27me3 within the Atm −/− peak predicted by sequencing and peak-finding, confirming our ChIPseq analysis. We next performed microarray analysis on RNA samples from wildtype and Atm −/− cerebellar cortex. Topping the list of downregulated genes were several associated with Purkinje and granule cells, such as Purkinje cell protein 2 (Pcp2, also known as L7), gamma-amino butyric acid A receptor subunit alpha 6 (Gabra6), and engrailed-1 and engrailed-2 (En1, En2) ( Fig. 3d ). Moreover, several neuronal genes described above on the basis of enrichment of H3K27me3 in their promoters' regions-Mef2a, Cdk5rap2, Slit1, Synj2 and Nlgn1were among the downregulated genes identified by expression array (Supplementary Tables 2 and 3) . The gene ontology analysis of the downregulated genes also highlighted developmental processes ( Supplementary Table 4 ). To assess the direct effect of enrichment of H3K27me3 in the promoter regions of these genes, we examined mRNA expression in wild-type and Atm −/− cerebella. In agreement with the microarray data, we found a significant reduction of gene expression in Atm −/− samples (Fig. 3e) . Although consistent with the ChIP data, we note that the loss could be due in part to the death of these cell types, as well as to reduced gene expression.
EZH2 has a direct effect on postmitotic neurons
Our previous work on HDAC4 had led us to conclude that the ATM-dependent effects on histone acetylation were independent of DNA damage. By contrast, ATM-mediated EZH2 phosphorylation responds robustly to DNA damage ( Fig. 2c) . To pursue this difference, we treated normal human fibroblasts or differentiated rodent N2a cells with ionizing radiation. In control fibroblasts we saw a reduction of EZH2 and H3K27me3 (Fig. 4a-c) , while in A-T fibroblast lines ionizing radiation had virtually no effect. Log phase N2a cells responded in a manner similar to that of ATM-deficient fibroblasts (Fig. 4a,c) , suggesting that the ATM effect was more pronounced in differentiated, nonmitotic cells.
We next asked whether ATM-mediated EZH2 phosphorylation was involved in the ability of ATM to regulate the neuronal cell cycle. a r t I C l e S In differentiated N2a cells, EZH2-2SA, but not wild type or EZH2-2SD, significantly increased the level of BrdU incorporation ( Fig. 4d,e ). We found the same effect of an acute reduction of EZH2 in primary ATM-deficient neurons by using EZH2 short hairpin RNA (shEzh2) lentiviral particles. The efficiency of viral infection was determined by examining EZH2 and H3K27me3 level ( Supplementary Fig. 6a ).
As expected, knockdown of EZH2 significantly blocked BrdU incorporation ( Fig. 5a,b) . There was no effect from EZH1 shRNA (shEzh1) infection. Knocking down EZH2 also prevented etoposide-induced activation of the cell death pathway in Atm −/− primary neurons (Fig. 5c,d) , consistent with the defective DNA damage response found in the A-T brain 34 . This reversal of the A-T cell cycle phenotype suggests that for neurons to keep their cell cycle in check they must maintain a constitutive ATM activity that keeps the levels of EZH2 low. We found that this suppression of EZH2-dependent histone methylation was also important for maintaining the proper structure of the neuronal dendrite. We measured spine density in cultured embryonic day 16.5 neocortical neurons from wild-type and Atm −/− brains. Mutant cortical neurons had a markedly reduced number of spines along a given length of dendrite (as previously reported for cerebellar Purkinje cells 35 ). Knockdown of EZH2, however, partially rescued this deficit and led to an increase of spine density in Atm −/− primary neurons (Fig. 5e,f) . For wild-type neurons, no marked changes occurred after shEzh2 infection. The improved Atm −/− dendritic structure achieved by decreasing EZH2 was associated with changes in mRNA for specific neuronal genes. Using qPCR after shEzh2 infection, we found significant increases in neuronal mRNAs, such as Slit1, Synj2 and Nlgn1 (Supplementary Fig. 6b,c) . By contrast, the mRNA levels of cell cycle regulatory genes, such as Pcna and Ccna1 (cyclin A), were decreased ( Supplementary Fig. 6b,d) .
Ezh2 knockdown prevents neurodegeneration in Atm −/− mice Previous studies have documented a degenerative process in Atm tm1Bal mutant mouse cerebellum 10, 12, 31 . To examine the effect of Ezh2 knockdown on this process, we surgically delivered shEzh2-GFP-expressing npg a r t I C l e S lentivirus into adult mouse cerebellum. Three to 4 weeks after virus delivery, we evaluated the efficiency of the EZH2 shRNAs both by GFP expression (Supplementary Fig. 7a ) and by the level of EZH2 immunoreactivity (Supplementary Fig. 7b ). The elevated levels of EZH2 in Atm −/− cerebellum were reduced after shEzh2 infection; the same virus had little effect in wild-type brains. Additionally, immunostaining revealed a dramatic reduction of H3K27me3 in cerebellar neurons of shEzh2-injected Atm −/− mice (Supplementary Fig. 7b) . We also monitored cell cycle reentry and the initiation of cell death in these preparations. In Atm −/− cerebellar GFP-positive neurons, reduction of EZH2 and H3K27me3 not only reduced the expression of cell cycle proteins such as cyclin A (Fig. 6a,b) and PCNA ( Supplementary  Fig. 8a) , it also partially inhibited the activation of caspase-3 ( Fig. 6c,d) . The Purkinje cell marker calbindin also revealed a substantial attenuation of Atm −/− Purkinje cell atrophy after injection of shEzh2 (Fig. 6e,f) .
We next sought to determine whether these in vivo improvements in the molecular profile of the Atm −/− cerebellar neurons was reflected in their cytological properties. While a previous study found no evidence of Purkinje cell loss in Atm tm1Awb/tm1Awb (ref. 36) , by applying the optical fractionator cell counting technique, we found a slight reduction in Purkinje cell counts in Atm tm1Bal homozygous mice ( Supplementary Table 5 ). This difference was too small, however, to serve as a reference for lentiviral shEzh2 rescue. We therefore analyzed the structural properties of Purkinje cells in a 2-mmdiameter area surrounding the injection site of the shEzh2-encoding lentivirus and found several important changes. First, by hematoxylin and eosin staining we noted a reduction in the number of Purkinje cells with the large cytoplasmic vacuoles described previously 10, 31 ( Supplementary Fig. 8b) . In addition, when we stained mouse cerebellum using the rapid Golgi stain technique ( Supplementary  Fig. 9 ), we noted changes in both the dendrites and spine density of the Purkinje cells in the infected areas. Although there was no significant difference in Purkinje cell density between wild-type and Atm −/− cerebella with or without shEzh2 viral infection, we found that the cross-sectional Purkinje cell dendritic profile area was reduced in untreated Atm −/− mice compared to wild type (Fig. 6g,h and Supplementary Table 6 ). This shrinkage was reversed in the areas surrounding the injection, and the difference between injected and uninjected brains was significant. Furthermore, knockdown of Ezh2 significantly increased the spine density of Purkinje cells in Atm −/− mice in contrast to controls (Fig. 6g,i) .
To verify the direct effect of loss of ATM-mediated EZH2 phosphorylation on the degenerative process of Purkinje cells in ATM deficiency, we co-injected lentiviral particles encoding human wildtype EZH2, the 2SA nonphosphorylatable mutant or the 2SD phosphomimetic mutant, together with Ezh2 shRNA (which is specific for the mouse Ezh2 message) into the cerebella of wild-type and Atm −/− a r t I C l e S adult mice. One week after injection of the two lentiviruses, we monitored gene transfer by immunohistochemistry using a human-specific EZH2 antibody ( Fig. 7 and Supplementary Fig. 10) . In infected Atm −/− cerebellar neurons, EZH2-2SD prevented cell cycle reentry (Fig. 7a,d) and caspase-3 activation (Fig. 7b,e) , as well as Purkinje cell atrophy (Fig. 7c,f) . By contrast, the EZH2-2SA nonphosphorylatable mutant resulted in cell cycle reentry and caspase-3 activation, as well as Purkinje cell atrophy, in both Atm −/− and wild-type mice. As expected, wild-type human EZH2 directly led to cyclin A and caspase-3 reappearance in the Atm −/− mutant but not in the wild type; however, overexpression of unmodified human EZH1 had little effect on either wild-type or Atm −/− neurons.
Ezh2 knockdown improves behavior of Atm −/− mice Although Atm mutant mice lack the profound ataxia found in human A-T, they do have reduced motor coordination compared to wild-type mice 12, [37] [38] [39] . Therefore, to test the role of enhanced EZH2 stability in this phenotype, we injected shEzh2-encoding lentiviral particles into mouse cerebellum at postnatal day (P) 18-an age at which the areas reached by viral infection should be greater than in the adult.
Three weeks after intracerebellar infusions, when transgene expression should be maximal, we subjected animals to rota-rod testing and measured locomotor activity in an open field. In the rota-rod test, the shEzh2-injected Atm −/− mice showed a significant delay in falling (P = 0.0019) compared to Atm −/− mutants infused with shEzh1 or shGapdh (Fig. 8a) .
Furthermore, spontaneous open field activity (measured as distance traveled) was significantly greater in shEzh2-injected Atm −/− mice, approaching wild-type values (Fig. 8b) .
A secondary parameter of ataxic behavior, rearing, was also different dependent on genotype and treatment. Wild-type mice reared more often (P = 0.027) than mutants receiving virus encoding shEzh1 or shGapdh. However, shEzh2-treated Atm −/− mice showed a reversal of the deficiency (Fig. 8c) .
DISCUSSION
We have previously shown that nuclear accumulation of HDAC4 is critical for A-T neurodegeneration 12 . Here we have uncovered a role for EZH2-mediated histone methylation in the A-T neurodegenerative process. In A-T and Atm −/− mouse brain, histone H3K27 trimethylation showed a significant increase. Further, in the absence of ATM the histone methyltransferase EZH2 was stabilized, was more readily incorporated into the PRC2 complex and displayed enhanced binding to H3K27. We quantified the elevation in H3K27me3 by a genome-wide analysis that represents, to our knowledge, the first unbiased, high-resolution mapping of H3K27me3 occupancy in the ATM-deficient brain. The increase in chromatin sites where H3K27me3 associates in Atm −/− brain is correlated with a shift in the expression of a variety of cell cycle and neurotrophic genes. The result is an EZH2-induced increase in neuronal process degeneration, cell cycle reentry, suppression of neuronal genes and induction of the apoptotic process. The physiological relevance of these changes in the epigenome is underlined by our finding that knockdown of EZH2 can partially rescue the behavioral disabilities found in Atm −/− mice, a finding with immediate therapeutic interest. In the EZH2 was discovered on the basis of its functions during embryogenesis, yet the current work highlights its importance to signaling in the adult brain. Other kinases have also been shown to modulate adult EZH2 activity, including AKT, CDK1, CDK2 and p38 kinase 15, 25, 40, 41 . Adding ATM to this list further integrates the pattern of histone methylation into the signaling activity of a cell by providing evidence that the levels and location of H3K27me3 can respond to DNA damage and oxidative stress. This can be seen directly in the alteration of EZH2 levels observed after ionizing radiation or etoposide treatment. We note that while Cdk1-mediated EZH2 phosphorylation increases H3K27 methylation 15, 30 , AKT-mediated EZH2 phosphorylation on Ser21 prevents it 41 . This suggests that EZH2 regulation in response to a change in cellular state is complex and bidirectional.
ATM deficiency leads to enhanced histone methylation, which is generally associated with a more compact form of chromatin. The observation that DNA damage, which activates ATM, leads to a substantial reduction in histone methylation suggests that activated ATM, by accelerating the degradation of EZH2, would be expected to reduce chromatin condensation. This would lead to a more open chromatin structure that could aid in the access of the various DNA repair proteins to the injured double helix and suggests a new and previously unrecognized way in which ATM helps in the DNA repair process. We note that this concept is fully consistent with work showing slower rates of DNA repair in heterochromatin than in euchromatin 42 . Previous studies indicate that EZH2 helps determine cancer cell response during the DNA damage response 43 ; two additional studies demonstrate that EZH2 contributes to cancer progression 44, 45 . Thus, our data suggest that ATM-mediated degradation of EZH2 during the DNA damage response is likely to serve a protective function in brain.
As ATM activity increases, not only would histone methylation decrease, but because HDAC4 would be less likely to move to the nucleus, histone deacetylation should decrease 12 . These two changes would act in concert with one another; both changes in the histone code would favor a more open chromatin configuration and thus more efficient DNA repair. Further insight into the consequences of the ATM-dependent changes in the histone code can be achieved by comparing the H3K27me3 sites defined in this study with the nuclear HDAC4 chromatin binding we reported previously 12 (Supplementary Fig. 11 ). The locations of the two marks overlap at only ~2% of the sites in the wild type. In ATM deficiency, however, the overlap increases to more than 5%. The dual epigenetic marks would be predicted to induce gene silencing in the Atm mutant. The H3K27me3-HDAC4 intersection peaks also appear to be particularly enriched in areas likely to contain cis-acting regulatory sequences. This can be seen most easily by comparing the distribution of these areas with those defined by randomly selected peak sets. Therefore, the H3K27me3-HDAC4 intersections are more likely to select marks within a reasonable cis-acting distance of a gene and are therefore more likely to regulate adjacent gene expression. It should be noted that while it may be important in determining the A-T phenotype, this overlapping subset of marks comprises only a small fraction of the total, suggesting that the two systems-methylation and acetylation-have largely independent functions.
In conclusion, our study presents evidence to suggest an expanded epigenetic regulatory model for the neurodegenerative process in A-T. ATM deficiency leads to abnormal alteration in the EZH2-dependent polycomb epigenetic system. We propose that changes in the status of genes affecting cell cycle and neuronal survival in the A-T brain not only depends on the consequences of HDAC4 nuclear accumulation, it also relies on PRC2 complex-mediated H3K27me3 changes. Identification of a role for ATM in the polycomb silencing system expands our understanding of the dynamic changes underlying histone modifications in A-T neurodegenerative processes and suggests new therapeutic targets for treatment.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Antibodies and chemical reagents. Antibodies against EZH1 (ab176115), EZH2 (ab3748), EED (ab126542), SUZ12 (ab12073), aldolase C (ab87122), calbindin (ab82812), H3K27me3 (ab6002), BrdU (ab6326) and cleaved caspase3 (ab52293) were obtained from Abcam (1:1,000). Antibodies against EZH2 (5246), H3K27me3 (9756), H3K9me3 (5327), total histone 3 (4620) and phospho-S/T[Q] (2851) were obtained from Cell Signaling (1:500). Antibodies against cyclin A (sc-751), cyclin D1 (sc-753) and β-actin (sc-130300) were from Santa Cruz (1:100). Secondary antibodies used for immunocytochemistry were as follows: Alexa 488-labeled chicken anti-mouse (A21200) or anti-rabbit (A21441); Alexa 594-labeled donkey anti-mouse (A21203) or anti-rabbit (A21207) (Invitrogen, Eugene, OR); all secondary antibodies were used at a dilution of 1:500. DAPI (4,6-diamidino-2-phenylindol) was used as a nuclear counterstain at 1 µg/ml. Animals. Atm tm1Bal/+ mice were a gift from Y. Xu. Timed pregnancies were established from these matings; the date of appearance of a vaginal plug was considered embryonic day (E) 0.5. Embryos were taken at embryonic day (E) 16.5 for either cortical cultures or histology. Animals were allowed to survive for 7 d before sacrifice. All animal procedures were reviewed, approved and carried out in accordance with Rutgers University IACUC standards. The animal facilities at Rutgers University are fully AAALAC accredited.
Human fibroblast and n2a cell culture. All human control and A-T primary fibroblast cell lines described in this paper were purchased from the Coriell Cell Repository. Fibroblasts were cultured in fibroblast medium (Dulbecco's modified Eagle's medium (DMEM) supplemented with 15% FBS (Hyclone), 1 mM glutamine (Invitrogen), 1% nonessential amino acids (Invitrogen) and penicillin/streptomycin (Invitrogen)). N2a cells were cultured in DMEM medium supplemented with 10% FBS. To differentiate N2a cells, 24 h after seeding culture medium was replaced by DMEM with 1 mM dbcAMP and 0.25% FBS. Cells were kept in this differentiation medium for 3-7 d before use.
Primary neuronal cultures.
Embryonic cortical neurons were isolated by standard procedures. For ATM-deficient cultures, all embryos from an Atm tm1Bal/+ × Atm tm1Bal/+ mating were collected and treated separately, then retrospectively genotyped by PCR. Isolated E16.5 embryonic cerebral cortices were treated with 0.25% trypsin-EDTA and dissociated into single cells by gentle trituration. Cells were suspended in Neurobasal medium supplemented with B27 and 2 mM glutamine, then plated on coverslips or dishes coated with poly-l-lysine (5 mg/mL). All cultures were grown for a minimum of 5 days in vitro (DIV) before any treatment. All experiments were performed on a minimum of three cultures from three separate embryos; each condition was examined in triplicate. All transfections were carried out using Lipofectamine 2000 after 4-5 DIV. Live imaging of GFP was performed on a heated stage in a controlled 5% CO 2 atmosphere at 7-10 DIV.
Immunohistochemistry. For DAB/brightfield staining, all paraffin-embedded human sections were deparaffinized in xylene and then rehydrated through graded ethanol to water. The sections were pretreated in 0.3% hydrogen peroxide in methanol for 30 min to remove endogenous peroxidase activity, rinsed in Tris-buffered saline (TBS) and then treated with 0.1 M citrate buffer in a microwave at sufficient power to keep the solution at 100 °C for 20 min. Sections were cooled in the same buffer at room temperature (RT) for 30 min and rinsed in TBS. Slides were incubated in 10% goat serum in PBS blocking solution for 1 h at RT, after which primary antibody was applied to the sections, which were then incubated at 4 °C overnight. The sections were washed three times in TBS before applying biotinylated goat anti-mouse (BA-9200) or anti-rabbit (BA-1000) secondary antibody (Vector Laboratories). Secondary antibody was applied for 1 h at RT. Afterwards, sections were rinsed three times in TBS. Rinsed sections were then incubated in Vectastain ABC Elite reagent for 1 h and developed using diaminobenzidine, according to the protocol of the manufacturer (Vector Laboratories). The sections were counterstained with hematoxylin, and after dehydration all sections were mounted in Permount under a glass coverslip. Control sections were subjected to the identical staining procedure, except for the omission of the primary antibody.
Immunofluorescence. All paraffin-embedded human sections were deparaffinized in xylene and then rehydrated through graded ethanol to water and PBS. For the mouse, cryostat sections were first rinsed in PBS. Subsequent steps were identical for paraffin and cryostat material. After rehydration, sections were treated in antigen-unmasking solution (low pH; Vector Laboratories) for 30 min at 100 °C. After the slides had cooled in buffer for 30 min at room temperature, slides were rinsed in PBS. Then sections were incubated in 10% goat serum in PBS for 1 h at room temperature to block nonspecific binding. All primary antibodies were diluted in PBS containing 0.5% Triton X-100 and 5% goat serum and incubated with sections overnight at 4 °C. After rinsing in PBS, they were incubated for 1 h with secondary antibody, which was conjugated with various fluorescently labeled secondary antibodies. All sections were mounted in ProLong Gold antifade reagent with DAPI (Invitrogen) under a glass coverslip. All experiments were conducted in triplicate.
chIP-quantitative real-time PcR. After immunoprecipitation, recovered chromatin fragments were analyzed by real-time PCR using primer pairs specific for 150-250-base-pair (bp) segments corresponding to mouse gene promoter regions (regions upstream of the start codon, near the first exon). Real-time PCR was performed using Express SYBRGreenER qPCRSupermix Universal (Invitrogen) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The relative quantities of immunoprecipitated DNA fragments were calculated by comparison with a standard curve generated by serial dilutions of input DNA. Data were derived from three independent amplifications. All PCR primer sequences can be found in Supplementary Table 7 .
RnA extraction and reverse transcription PcR. RNA was prepared using PureLink micro-to-midi total RNA purification system (Invitrogen). Semiquantitative RT-PCR was performed with Superscript III one-step RT-PCR system with platinum Taq High Fidelity (Invitrogen). For quantitative real-time PCR, cDNA was prepared by using oligonucleotide (dT) or random primers and a Thermo Reverse Transcription kit (Signalway Biotechnology). All qPCRs were performed using Express SYBRGreenER qPCR Supermix Universal (Invitrogen) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). The mRNA level of Tuba1a (tubulin) or Rplp0 (36B4) was used as an internal control. All RT-PCR primers are shown in Supplementary Table 8 .
western blotting and immunoprecipitation. For western blots, protein extracts from mouse tissue or primary cultures were separated with SDS-PAGE. For immunoprecipitation, protein extracts were subsequently incubated for overnight at 4 °C with the primary antibodies and protein G Dynabeads (Invitrogen). The precipitates were washed twice with a lysis buffer and then were resolved on an SDS-PAGE gel.
In vitro kinase assay. N2A cells overexpressing wild-type Flag-ATM were lysed in TNN buffer and immunoprecipitated with 20 µl protein G Dynabeads and 5 µg anti-Flag antibody (Sigma, F1804). Kinase reactions were performed using precipitated ATM on beads (~15 µl) with either GST-tagged EZH2, the GST-tagged EZH2-S734A and GST-tagged EZH2-2SA purified from bacteria (~1 µg protein) npg
